Therapeutic targeting of HYPDH/PRODH2 with N-propargylglycine offers a Hyperoxaluria treatment opportunity is a research paper published in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2023). On theSindex it has a DataRank of 0.312. It has been cited 7 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.312
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NCI NIH HHS
Grant: U24 CA210990
NIGMS NIH HHS
Grant: R01 GM132640
NIA NIH HHS
Grant: U54 AG075932
NINDS NIH HHS
Grant: R01 NS100529
National Institutes of Health
Grant: 5R01NS100529-04
Identifying Factors Regulating Medium Spiny Neuron Differentiation or Maintenance as Therapeutic Targets for Huntington's Disease using Induced Pluripotent Stem Cells
National Institutes of Health
Grant: 2R01GM132640-03
Investigating the Proline Cycle as a Potential Cancer Therapy Target
National Institutes of Health
Grant: 5U24CA210990-04
UCSC-Buck Specialized Genomic Data Analysis Center for the Genomic Data Analysis Network
National Institutes of Health
Grant: 1U54AG075932-01
Senescent cell mapping, identification and validation for human somatic and reproductive tissues
Fields of Study
MeSH Terms
Keywords